BOCSCI Inc.

BOCSCI Inc., operating under the brand BOC Sciences, is a premier chemical manufacturing and service company headquartered in Shirley, New York. With a workforce of 501 to 1,000 employees, the company functions as a full-service Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO). BOCSCI Inc. supports the pharmaceutical, biotechnology, and agrochemical industries through a comprehensive suite of services that span the entire molecule development pipeline, from target identification and preclinical research to clinical studies and commercialization. The company specializes in the development and distribution of high-quality research chemicals, biochemicals, and biologics. Its extensive product portfolio includes small molecules, inhibitors, building blocks, Antibody-Drug Conjugates (ADCs), peptides, nucleosides, and active pharmaceutical ingredients (APIs). BOCSCI Inc. is particularly recognized for its advanced technology platforms in nano-formulation development, including LNP and liposome systems, as well as its expertise in aesthetic medicine biomaterials such as hyaluronic acid and botulinum toxin. Operating GLP-compliant bioanalytical and pharmaceutics laboratories, BOCSCI Inc. provides specialized services in drug design, compound synthesis, and DMPK/ADME studies. The company offers flexible OEM and contract manufacturing roles, providing custom synthesis and diverse packaging options ranging from milligrams to bulk quantities. With over a decade of experience as a premium supplier, BOCSCI Inc. leverages its global partnerships and scientifically rigorous quality systems to accelerate innovation for research institutions and pharmaceutical companies worldwide.